Sly syndrome

Sly Syndrome is a rare genetic disorder characterized by a deficiency of the enzyme beta-glucuronidase. This enzyme is required for the breakdown of large sugar molecules called glycosaminoglycans (GAGs). Sly Syndrome is also known as Mucopolysaccharidosis type VII (MPS VII) or Beta-glucuronidase deficiency.

Symptoms

The symptoms of Sly Syndrome can vary widely among affected individuals. They may include hydrops fetalis, skeletal abnormalities, short stature, coarse facial features, hepatosplenomegaly, cardiovascular abnormalities, and developmental delay.

Causes

Sly Syndrome is caused by mutations in the GUSB gene. This gene provides instructions for producing the enzyme beta-glucuronidase. Without this enzyme, GAGs accumulate in the cells, leading to the various symptoms of Sly Syndrome.

Diagnosis

Diagnosis of Sly Syndrome is based on a clinical examination, detailed patient history, and specialized tests such as enzyme analysis or genetic testing. Prenatal diagnosis is also possible through amniocentesis or chorionic villus sampling.

Treatment

There is currently no cure for Sly Syndrome. Treatment is symptomatic and supportive, and may include physical therapy, surgery to correct bone abnormalities, and enzyme replacement therapy.

Prognosis

The prognosis for individuals with Sly Syndrome varies depending on the severity of symptoms. Some individuals have a normal lifespan, while others may have life-threatening complications in infancy or early childhood.

See also

• Mucopolysaccharidoses
• Lysosomal storage disorders
• Genetic disorders

References

Sly syndrome Resources
Latest articles Most recent articles Ongoing trials	Wikipedia